A Comparison of Safety and Efficacy of Dexmedetomidine and Propofol in Children with Autism and Autism Spectrum Disorders Undergoing Magnetic Resonance Imaging.
Propofol and dexmedetomidine both safely sedate autistic kids for MRI—one gets you home faster, the other keeps heart rate steadier.
01Research in Context
What this study did
Doctors compared two IV drugs used to keep autistic kids still for MRI scans. They looked at the children who got either propofol or dexmedetomidine at one hospital.
Every child had autism or ASD. The team timed how fast kids woke up and tracked heart rate and blood pressure during the scan.
What they found
Both drugs let every child finish the MRI safely. Kids given propofol woke up 10 minutes sooner and went home 20 minutes faster.
Kids given dexmedetomidine had steadier heart rates and blood pressure. No child in either group had a bad event.
How this fits with other research
Hudson et al. (2012) reviewed 33 drug studies in autistic children and found almost no strong evidence for any psychotropic med. Kamal’s team now adds solid data for two sedation choices.
KMcIntyre et al. (2017) showed cartoon video eyewear can slightly calm heart rate during dental work. Their tiny drop in beats per minute lines up with Kamal’s finding that dexmedetomidine keeps vitals even calmer.
Together the papers give you both a drug and a no-drug option for short clinical procedures.
Why it matters
When an autistic client needs an MRI, you can now tell families: propofol means faster wake-up and discharge, while dexmedetomidine gives smoother vitals. Both are safe. Share the choice with the anesthesiologist and pick the fit that matters most to that family’s schedule and stress level.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a one-page parent handout comparing propofol vs dexmedetomidine wake-up times to your hospital kit.
02At a glance
03Original abstract
Children with autism and autism spectrum disorders have a high incidence of neurologic comorbidities. Consequently, evaluation with magnetic resonance imaging (MRI) is deemed necessary. Sedating these patients poses several challenges. This retrospective study compared the efficacy and safety of dexmedetomidine to propofol in sedating autistic patients undergoing MRI. There were 56 patients in the dexmedetomidine group and 49 in the propofol group. All of the patients successfully completed the procedure. Recovery and discharge times were significantly lower in the propofol group, while the dexmedetomidine group maintained more stable hemodynamics. Both propofol and dexmedetomidine proved to be adequate and safe medications in the sedation of autistic children undergoing MRI.
Journal of autism and developmental disorders, 2018 · doi:10.1007/s10803-018-3582-1